SEATTLE -- Adding beta-hydroxybutyrate (BHB) stopping criteria cut down fasting time when detecting insulinomas in patients with hypoglycemia, according to late-breaking findings presented here. By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback